Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy
Tumor-derived membrane vesicles (TDMVs) are non-invasive, chemotactic, easily obtained characteristics and contain various tumor-borne substances, such as nucleic acid and proteins. The unique properties of tumor cells and membranes make them widely used in drug loading, membrane fusion and vaccines...
Main Authors: | Jiabin Xu, Wenqiang Cao, Penglai Wang, Hong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/7/876 |
Similar Items
-
Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications
by: Wenjuan Chen, et al.
Published: (2022-11-01) -
Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy
by: Qiujun Zhou, et al.
Published: (2022-12-01) -
Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
by: Irene Fernández-Delgado, et al.
Published: (2020-11-01) -
Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy
by: Xiaoyu An, et al.
Published: (2023-12-01) -
The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
by: Yongmin Li, et al.
Published: (2023-07-01)